AGB101 Clinical Trials
2 recruitingDrug
Phase 22
Showing 1–2 of 2 trials
Recruiting
Phase 2
Clinical Trial Evaluating the Efficacy of AGB101 for Reducing Hippocampal Overactivity in Older Adults
DementiaHippocampal Overactivity
Johns Hopkins University60 enrolled1 locationNCT06919926
Recruiting
Phase 2
Clinical Trial Evaluating the Efficacy and Safety of AGB101 for Treatment of Parkinson's Disease Related Psychosis
Parkinson Disease Psychosis
Johns Hopkins University30 enrolled1 locationNCT05824728